Navigation Links
Cell Therapeutics, Inc. Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants
Date:12/8/2011

shares of common stock and have no voting rights on general corporate matters.

The closing of the offering is expected to occur on December 13, 2011, at which time the Company will receive the cash proceeds and deliver the securities.

Rodman & Renshaw, LLC, a wholly-owned subsidiary of Rodman & Renshaw Capital Group, Inc., (Nasdaq: RODM), acted as the exclusive placement agent for the offering. Trout Capital LLC provided financial advisory services.

A shelf registration statement relating to the shares of Series 14 Preferred Stock and warrants issued in the offering (and the shares of common stock issuable upon conversion of the Series 14 Preferred Stock and exercise of the warrants) has been filed with the Securities and Exchange Commission (the "SEC"). A prospectus supplement under Rule 424 of the Securities Act of 1933, as amended, relating to the offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus may be obtained directly from the Company by contacting the Company at the following address: Cell Therapeutics, Inc., 501 Elliott Avenue West, Suite 400, Seattle, Washington 98119. This press release does not constitute an offer to sell or a solicitation of an offer to buy the Series 14 Preferred Stock or warrants (or the shares of common stock issuable upon conversion of the Series 14 Preferred Stock and exercise of the warrants). No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading prices of the Company's securities. The risks and uncertainties include the risk that the purchase and sale of the Series 14 Preferred Stock
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO Investor Forum
2. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
3. Reed V. Tuckson, M.D., Executive Vice President and Chief of Medical Affairs at UnitedHealth Group, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
4. Intrinsic Therapeutics, Inc. Names Cary P. Hagan as President & CEO
5. Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation
6. Prefilled Syringes: Devices, Therapeutics, Players, Markets and Prospects
7. Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
8. Cell Therapeutics, Inc. (CTI) Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market
9. Cell Therapeutics, Inc. Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants
10. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
11. Serina Therapeutics, Inc. Closes $9.5 Million Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... announced today that it will release its full financial results ... May 11 th before the open, followed by a ... results and business outlook. Participants should call (888) ... (International) and request the InspireMD call. A live webcast of ...
(Date:5/5/2015)... , May 5, 2015 GW Pharmaceuticals ... "Company"), a biopharmaceutical company focused on discovering, developing ... product platform, announced today the closing of the ... by GW of 1,600,000 American Depositary Shares (ADSs) ... gross proceeds of approximately $179.2 million (before deducting ...
(Date:5/5/2015)... , May 5, 2015 /CNW Telbec/ - ... Laval and known under the « ... the closing of the transaction previously announced on April ... issued and outstanding  shares of Orthoconcept (2008) inc.   ... 500 000 common shares (TSXV: ERG) to the vending ...
Breaking Medicine Technology:InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3
... Associated Foot & Ankle Specialists,today announced it ... diabetes,to participate in the MATRIX clinical trial. The ... Excellarate, for the potential treatment of,patients with non-healing ... to stimulate the process of wound healing., ...
... to Healthcare Market, ORLANDO, Fla., Feb. ... (NYSE: HRS ), an international communications ... Cancer Treatment,Services International (CTSI) to advance the ... provide advanced imaging and information,systems that assure ...
Cached Medicine Technology:Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment 2
(Date:5/6/2015)... 2015 The beverage industry has grocery ... Miracles organic tea and superfruit fusions stands out among ... sweetened with agave, these delicious juice blends are making ... healthier ways to hydrate. , In collaboration with National ... to raise a bottle of Lemongrass Tea and Ginseng, ...
(Date:5/5/2015)... With ProPoint: Hand Drawn, users can point, underline, ... X . With ProPoint: Hand Drawn, users can also ... customize each preset all with a click of a mouse. ... fully customizable effect presets all within Final Cut Pro X. ... underlines, and more. , ProPoint: Hand Drawn on-screen controls ...
(Date:5/5/2015)... May 05, 2015 Private equity consultant ... LLC has announced that its dental stem cell biobank ... increased once again--in April, 2015 –and posted yet another ... increased record volume and represents a significant 54% increase ... stem cell biobank is conducted via the Store-A-Tooth brand. ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Carlini CPA, ... Trail, Monroe, Matthews, Charlotte and surrounding areas. The company ... of accounting. This company provides assistance in making informed ... they prepare individual or corporate tax returns for their ... the cloud that allows clients (and Carlini CPA) to ...
(Date:5/5/2015)... AxoGen, Inc. (NASDAQ: AXGN), a ... peripheral nerve repair market, reported record revenue of $4.95 ... compared to $3.14 million in the year-ago first quarter. ... portfolio of nerve repair products - Avance® Nerve ... and our solid sales execution delivered another record quarter ...
Breaking Medicine News(10 mins):Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4
... Q2 2007 Levels, - STAAR Announces Internet Marketing Campaign with ... ... MONROVIA, Calif., June 12 STAAR Surgical,Company (Nasdaq: STAA ), a ... Visian ICL(TM),(Implantable Collamer Lens) sales in the U.S. for the second quarter ...
... for Model Evaluation; Dr. Mike Dunlavey Will Present Simplified ... ... June 12 Pharsight,Corporation (Nasdaq: PHST ), a leading ... drug,development, today announced that Pharsight software development experts,will deliver two ...
... time is associated with overweight in children and adolescents, ... reduced REM sleep, according to a research abstract that ... 22nd Annual Meeting of the Associated Professional Sleep Societies ... PhD, of the University of Pittsburgh, focused on 335 ...
... has announced that it has,been awarded the prestigious Emerging ... Wound Management category., KFH,s CEO, Henk Snyman, MD, ... respected company such as Frost & Sullivan. We have,achieved ... to create,a continuous stream of state-of-the-art, portable medical devices ...
... Mich. A type of stroke that can strike at ... be more common in women and Mexican-Americans than in non-Hispanic ... of Michigan Stroke Program. , In a paper published online ... report that women had a 74 percent greater chance of ...
... GROVE, Ill., June 11 Lifeway Foods,Inc., (Nasdaq: ... kefir, announced today that they are now using milk ... certified hormone free milk comes,with a Farmers Pledge, which ... change came as a response to a growing demand ...
Cached Medicine News:Health News:STAAR Surgical's LASIK Alternative Expands U.S. Market Gains 2Health News:STAAR Surgical's LASIK Alternative Expands U.S. Market Gains 3Health News:STAAR Surgical's LASIK Alternative Expands U.S. Market Gains 4Health News:Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting 2Health News:Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting 3Health News:REM sleep associated with overweight in children and adolescents 2Health News:REM sleep associated with overweight in children and adolescents 3Health News:Kingfisher Healthcare (KFH) Wins Prestigious Frost & Sullivan Best Practices Award 2Health News:Women, Mexican-Americans at higher risk of ruptured brain aneurysm 2Health News:Women, Mexican-Americans at higher risk of ruptured brain aneurysm 3Health News:Lifeway Foods Switches to 100% Certified Hormone Free Milk 2
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
CranioFix2 is the next generation CranioFix Titanium Clamp System, which is up to 40% faster than the original CranioFix and all flap fixation systems on the market....
... P-2000 FastPach is an accurate, reliable, ... glaucoma screenings. It works off of ... charging of the device a breeze. ... controls make operating and viewing results ...
... PalmScan A2000] device is intended as a ... ultrasound,technology, and thus may be used to ... depth (ACD), and lens thickness (LT) of ... intended for calculating the optical power of ...
Medicine Products: